Windward Bio Group AG is clinical-stage biotechnology company, which developing long acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, COPD, and atopic dermatitis. It focuses on discovery, development, and manufacture of drug products for the treatment of immunological conditions. The company was founded by Luca Santarelli on July 05, 2024 and is headquartered in Basel, Switzerland.